---
figid: PMC10030587__fphar-14-1130747-g002
figtitle: 'Key events in cancer: Dysregulation of SREBPs'
organisms:
- NA
organisms_ner:
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC10030587
filename: fphar-14-1130747-g002.jpg
figlink: /pmc/articles/PMC10030587/figure/F2/
number: F2
caption: mTOR-dependent and mTOR-independent signaling pathways. In the mTOR-dependent
  signaling pathways, AKT/mTOR/SREBPs activate SREBPs in cancer cells. Numerous protein
  molecules can directly or indirectly (through AKT) act on mTOR, thereby regulating
  the activation of SREBPs. In the PI3K/AKT/mTOR/SREBP1 pathway, mTOR further enhances
  AKT signaling in melanoma cells through positive feedback. In the mTOR-independent
  pathway, HBXIP and PD-L1 act directly on SREBP1 and promote its activation. Mutation
  of the R132H site of IDH1, loss of p53, and FDXR all promote the activation of SREBP1
  and SREBP2.
papertitle: 'Key events in cancer: Dysregulation of SREBPs.'
reftext: Yunkuo Li, et al. Front Pharmacol. 2023;14:1130747.
year: '2023'
doi: 10.3389/fphar.2023.1130747
journal_title: Frontiers in Pharmacology
journal_nlm_ta: Front Pharmacol
publisher_name: Frontiers Media S.A.
keywords: SREBPs | lipid metabolism | fatty acids | cholesterol | cancer therapy
automl_pathway: 0.9032942
figid_alias: PMC10030587__F2
figtype: Figure
redirect_from: /figures/PMC10030587__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC10030587__fphar-14-1130747-g002.html
  '@type': Dataset
  description: mTOR-dependent and mTOR-independent signaling pathways. In the mTOR-dependent
    signaling pathways, AKT/mTOR/SREBPs activate SREBPs in cancer cells. Numerous
    protein molecules can directly or indirectly (through AKT) act on mTOR, thereby
    regulating the activation of SREBPs. In the PI3K/AKT/mTOR/SREBP1 pathway, mTOR
    further enhances AKT signaling in melanoma cells through positive feedback. In
    the mTOR-independent pathway, HBXIP and PD-L1 act directly on SREBP1 and promote
    its activation. Mutation of the R132H site of IDH1, loss of p53, and FDXR all
    promote the activation of SREBP1 and SREBP2.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - BSG
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - PKM
  - PKLR
  - YAP1
  - AKT1
  - AKT2
  - AKT3
  - KRAS
  - EPHB2
  - MAPK1
  - MAPK3
  - TNF
  - MTOR
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - SREBF1
  - SREBF2
  - IDH1
  - LAMTOR5
  - TP53
  - TP63
  - TP73
  - FDXR
  - CD274
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - yki
  - Akt
  - kra
  - kraken
  - Myd88
  - Erk7
  - rl
  - egr
  - Mtor
  - Tor
  - SNF4Agamma
  - AMPKalpha
  - SREBP
  - Idh
  - Lamtor5
  - p53
  - betaTub60D
  - hth
---
